Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Colorado at Denver and Health Sciences Center |
---|---|
Information provided by: | University of Colorado at Denver and Health Sciences Center |
ClinicalTrials.gov Identifier: | NCT00364221 |
The metabolic syndrome is a collection of health risks that includes obesity, high blood pressure, high triglycerides, high blood sugar, low good cholesterol, and resistance to insulin. The purpose of this study is to find out if the medication, rosiglitazone, influences levels of fat cell proteins and alters insulin resistance in nondiabetic persons with the metabolic syndrome. This is an early step to see if a medication, such as rosiglitazone, will be beneficial in people who have the metabolic syndrome.
Condition | Intervention | Phase |
---|---|---|
Metabolic Syndrome Insulin Resistance |
Drug: Rosiglitazone |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | The Effect of Rosiglitazone on Adipocyte-Derived Cytokines in Nondiabetics With the Metabolic Syndrome |
Ages Eligible for Study: | 30 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Colorado | |
University of Colorado at Denver and Health Sciences Center General Clinical Research Center | |
Denver, Colorado, United States, 80262 |
Principal Investigator: | Christina L Aquilante, PharmD | University of Colorado at Denver and Health Sciences Center |
Study ID Numbers: | COMIRB 04-0447 |
Study First Received: | August 14, 2006 |
Last Updated: | October 4, 2006 |
ClinicalTrials.gov Identifier: | NCT00364221 |
Health Authority: | United States: Institutional Review Board |
Hyperinsulinism Metabolic Diseases Insulin Resistance |
Metabolic disorder Glucose Metabolism Disorders Rosiglitazone |
Hypoglycemic Agents Pathologic Processes Disease |
Syndrome Physiological Effects of Drugs Pharmacologic Actions |